Howard Hughes Medical Institute’s Avangrid, Inc. AGR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-11,677
Closed -$499K 175
2017
Q1
$499K Sell
11,677
-9,124
-44% -$373K 0.09% 91
2016
Q4
$788K Sell
20,801
-184
-0.9% -$7.02K 0.18% 77
2016
Q3
$877K Sell
20,985
-788
-4% -$34.4K 0.23% 73
2016
Q2
$1M Sell
21,773
-12,038
-36% -$496K 0.34% 67
2016
Q1
$1.36M Buy
33,811
+1,236
+4% +$48.4K 0.3% 57
2015
Q4
$1.25M Buy
+32,575
New +$1.18M 0.19% 64

Other funds holding AGR

Howard Hughes Medical Institute's AGR Position: Q2 2017 in Review

Howard Hughes Medical Institute sold out of Avangrid, Inc. (AGR) in Q2 2017, closing a stake of 11,677 shares — an estimated $499K sold.

Howard Hughes Medical Institute first reported a position in AGR in Q4 2015 and held it in 6 quarters. The position peaked at $1.36M in Q1 2016. 224 funds tracked by Wall St. Rank hold AGR as of Q2 2017.

  • Howard Hughes Medical Institute reported no remaining Avangrid, Inc. position as of Q2 2017 after selling out during the quarter.
  • Howard Hughes Medical Institute sold 11,677 Avangrid, Inc. shares in Q2 2017, an estimated $499K.
  • Howard Hughes Medical Institute first reported a position in Avangrid, Inc. in Q4 2015 and held it in 6 quarters.
  • Howard Hughes Medical Institute's Avangrid, Inc. position peaked at $1.36M in Q1 2016.
  • 224 funds tracked by Wall St. Rank held Avangrid, Inc. as of Q2 2017.

Based on Howard Hughes Medical Institute's 13F filing for Q2 2017, filed 11 Aug 2017.